Anti-CD2_JJ
receptor_NN
antibodies_NNS
activate_VBP
the_DT
HIV_NN
long_JJ
terminal_JJ
repeat_NN
in_IN
T_NN
lymphocytes_NNS
._.

The_DT
CD2_NN
T_NN
lymphocyte_NN
glycoprotein_NN
surface_NN
molecule_NN
mediates_VBZ
both_CC
cell_NN
to_TO
cell_NN
adhesion_NN
and_CC
T_NN
cell_NN
activation_NN
,_,
two_CD
processes_NNS
that_WDT
are_VBP
involved_VBN
in_IN
the_DT
spread_NN
of_IN
HIV_NN
infection_NN
._.

Treatment_NN
of_IN
chronically_RB
HIV-infected_JJ
PBMC_NNS
with_IN
anti-CD2_JJ
mAb_NN
has_VBZ
been_VBN
shown_VBN
to_TO
induce_VB
the_DT
expression_NN
of_IN
infectious_JJ
virus_NN
from_IN
these_DT
cultures_NNS
._.

In_IN
this_DT
study_NN
we_PRP
investigated_VBD
the_DT
mechanisms_NNS
whereby_WRB
anti-CD2_JJ
antibodies_NNS
stimulate_VBP
viral_JJ
production_NN
._.

We_PRP
demonstrate_VBP
that_IN
treatment_NN
of_IN
transiently_RB
transfected_VBN
T_NN
lymphocytes_NNS
with_IN
anti-CD2_JJ
antibodies_NNS
results_VBZ
in_IN
activation_NN
of_IN
the_DT
HIV_NN
long_JJ
terminal_JJ
repeat_NN
._.

Furthermore_RB
,_,
CAT_NN
assays_NNS
using_VBG
mutated_VBN
HIV_NN
long_JJ
terminal_JJ
repeat-CAT_NN
constructs_NNS
and_CC
gel_NN
shift_NN
assays_NNS
demonstrate_VBP
that_IN
this_DT
activation_NN
is_VBZ
dependent_JJ
on_IN
the_DT
NF-kappa_NN
B_NN
enhancer_NN
._.

These_DT
studies_NNS
suggest_VBP
that_IN
interaction_NN
of_IN
CD2_NN
with_IN
its_PRP$
natural_JJ
ligand_NN
,_,
LFA-3_NN
,_,
may_MD
play_VB
a_DT
role_NN
in_IN
regulation_NN
of_IN
HIV_NN
expression_NN
._.

